This article summarized the latest R&D progress of Cangrelor, the Mechanism of Action for Cangrelor, and the drug target R&D trends for Cangrelor.

AcuraStem proclaimed it has signed a licensing deal with Takeda.

This article summarized the latest R&D progress of Calcifediol, the Mechanism of Action for Calcifediol, and the drug target R&D trends for Calcifediol.

SGLT1, or sodium-glucose co-transporter 1, plays a crucial role in the human body by facilitating the absorption of glucose and galactose in the small intestine.

This article summarized the latest R&D progress of Folinic acid, the Mechanism of Action for Folinic acid, and the drug target R&D trends for Folinic acid.

Alvotech revealed that its distribution associate in Japan, Fuji Pharma Co., Ltd., has obtained commercialisation authorization for AVT04 (ustekinumab).

This article summarized the latest R&D progress of Ephedrine Sulfate, the Mechanism of Action for Ephedrine Sulfate, and the drug target R&D trends for Ephedrine Sulfate.

RAS is a small G protein composed of 188 amino acids, primarily distributed on the inner membrane of the cytoplasm in cells, its activity undergoes dynamic changes.

This article summarized the latest R&D progress of Fluphenazine Decanoate, the Mechanism of Action for Fluphenazine Decanoate, and the drug target R&D trends for Fluphenazine Decanoate.

TransCode Therapeutics has reported positive findings with its primary treatment candidate, TTX-MC138, in mouse models with human glioblastoma multiforme tumors.

This article summarized the latest R&D progress of Hydrochlorothiazide/Lisinopril, the Mechanism of Action for Hydrochlorothiazide/Lisinopril, and the drug target R&D trends for Hydrochlorothiazide/Lisinopril.

RIPK1, also known as Receptor-interacting serine/threonine-protein kinase 1, is a multi-domain protein that includes an N-terminal kinase domain, intermediate domain, and a C-terminal death domain.